Fuso Chemical Co Ltd

Fuso Chemical Co Ltd maintains a strong liquidity position with a current ratio of 3.63 and cash and equivalents of ¥31.3 billion, which is well above the industry median for liquidity. The company's debt-to-equity ratio of 0.19 indicates a conservative capital structure, with long-term debt of ¥20.1 billion compared to total equity of ¥104.0 billion. Profitability metrics show a return on equity (ROE) of 11.17% and a return on assets (ROA) of 8.21%, both of which are above the industry median for Commodity Chemicals. The operating margin of 22.86% (calculated from operating income of ¥15.9 billion on revenue of ¥69.5 billion) reflects strong cost control and pricing power in its core markets. The company operates through two segments: Life Science and Electronic Materials and Functional Chemicals. The Life Science segment focuses on food additives and fruit acids, while the Electronic Materials segment targets high-purity colloidal silica for semiconductor applications. Revenue concentration is not disclosed, but the dual-segment model suggests diversification across applications and customer bases. Growth trajectory is supported by a positive outlook for FY2024, with revenue expected to increase by 4.5% year-over-year. Capital expenditures of ¥20.1 billion in the latest period indicate ongoing investment in production capacity and technology, particularly in the high-growth electronic materials segment. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's free cash flow was negative at ¥2.6 billion in the latest period, primarily due to high capital expenditures, but this is offset by strong operating cash flow of ¥22.7 billion. Recent events include the release of the latest financial results and analyst estimates, with a mean price target of ¥4,200 and a median of ¥4,100. Analysts have issued three positive recommendations (1 strong buy, 2 buys) with no holds or negative ratings.